文献速递神经肿瘤

荧光素钠在复发性多形性胶质母细胞瘤手术治疗中的应用

Fluorescein Sodium in the Surgical Treatment of Recurrent Glioblastoma Multiforme.
PubMed 文献 · World Neurosurg · 2019-01-22

该研究纳入106例复发性多形性胶质母细胞瘤患者,术前约45分钟按5 mg/kg体重静脉注射荧光素钠,使用YELLOW 560 nm滤镜辅助显微手术切除。术后48小时内MRI显示89例(84%)实现全切除,17例(16%)有残留,术后未观察到不良事件。作者认为荧光素钠联合YELLOW 560 nm滤镜是安全可行的工具,可能改善复发性胶质母细胞瘤的切除。

要点

  • 106例复发性胶质母细胞瘤患者中,89例(84%)实现全切除,17例(16%)有残留。
  • 所有患者均见明亮荧光染色,作者认为有助于肿瘤切除。
  • 术后未观察到不良事件,作者认为荧光素钠联合YELLOW 560 nm滤镜安全可行。

核心结论

  • 荧光素钠和YELLOW 560 nm滤镜是易于获得的荧光引导肿瘤切除方法,类似于T1加权MRI的对比增强。
  • 荧光素钠可能以极小风险改善复发性胶质母细胞瘤的切除,肿瘤边界清晰可见。
  • 荧光素钠和YELLOW 560 nm滤镜是用于复发性胶质母细胞瘤安全最大切除的安全可行工具。

研究设计与样本

  • 本研究为单中心经验报道,纳入106例复发性多形性胶质母细胞瘤患者(女53例,男53例;平均年龄53岁)。
  • 术前约45分钟按5 mg/kg体重静脉注射荧光素钠,使用YELLOW 560 nm滤镜(PENTERO 900,Carl Zeiss Meditec,Oberkochen,德国)辅助显微手术切除及切除控制。
  • 回顾手术报告评估荧光染色程度,术后48小时内复查MRI评估切除程度,并评估神经功能结局、并发症及不良事件。

主要发现

  • 所有患者均出现明亮荧光染色,显著增强肿瘤可视性,作者认为有助于肿瘤切除。
  • 术后MRI显示17例(16%)有残留肿瘤组织,89例(84%)实现全切除。
  • 术后未登记任何不良事件。

临床怎么用

  • 作者认为荧光素钠联合YELLOW 560 nm滤镜是安全可行的工具,可用于复发性胶质母细胞瘤的安全最大切除。
  • 作者认为荧光素钠可能以极小风险改善复发性胶质母细胞瘤的切除,肿瘤边界清晰可见。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Glioblastoma multiforme (GBM) is the most common primary brain tumor and has a high recurrence rate. Maximizing the extent of resection (EOR) in recurrent GBM has proved to be the cornerstone of neurosurgical retreatment. The development of surgical microscopes fitted with fluorescein-specific filters has facilitated fluorescein-guided microsurgery and the identification of tumor tissue. Use of fluorescein sodium (FL) in primary high-grade glioma resection has shown promising results. Here, we present our experience with FL and the dedicated surgical microscope filter YELLOW 560 nm in 106 patients with recurrent GBM. METHODS: A total of 106 patients with recurrent GBM were included (53 women, 53 men; mean age, 53 years). A total of 5 mg/kg bodyweight of FL was intravenously injected approximately 45 minutes before craniotomy. A YELLOW 560 nm filter (PENTERO 900 [Carl Zeiss Meditec, Oberkochen Germany]) was used for microsurgical tumor resection and resection control. Surgical reports were reviewed regarding the degree of fluorescent staining. Postoperative magnetic resonance images were examined within 48 hours after surgery regarding the EOR and postoperative course regarding neurologic outcome, complications, and any adverse events. RESULTS: Bright fluorescent staining was present in all patients, which markedly enhanced tumor visibility and was deemed helpful for tumor resection. Seventeen patients (16%) showed residual tumor tissue on postoperative magnetic resonance imaging (MRI). Therefore, gross total resection was achieved in 89 patients (84%). No adverse events were registered postoperatively. CONCLUSIONS: FL and YELLOW 560 nm are readily available methods for fluorescence-guided tumor resection, similar to contrast enhancement in T1-weighted MRI. FL may improve resection in recurrent GBM with minimal risk, and tumor margins are clearly visualized. FL and the YELLOW 560 nm filter are safe and feasible tools for safe maximal resection of recurrent glioblastoma.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Höhne J, Schebesch KM, de Laurentis C, et al. Fluorescein Sodium in the Surgical Treatment of Recurrent Glioblastoma Multiforme. World Neurosurg. 2019. PMID: 30682505. doi:10.1016/j.wneu.2019.01.024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。